📖

a2m

wiki page Created: 2026-04-02 13:40:08 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-genes-a2m

Related Entities

Metadata

slug	genes-a2m
entity_type	gene
kg_node_id	A2M

🌍 Provenance Graph 1 nodes, 0 edges

No provenance edges found

Linked Artifacts (441)

mentions🧪Circadian-Synchronized LRP1 Pathway Activation70%

mentions🧪Synthetic Biology BBB Endothelial Cell Reprogramming70%

mentions🧪Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides70%

mentions🧪Glycosaminoglycan Template Disruption Approach65%

related🧪Circadian-Synchronized LRP1 Pathway Activation63%

related🧪Synthetic Biology BBB Endothelial Cell Reprogramming63%

related🧪Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides63%

see_also📖AQP4 (Aquaporin-4 Gene)60%

see_also📖CXCL12 Gene60%

see_also📖ISG15 — Interferon-Stimulated Gene 1560%

see_also📖p2rx760%

see_also📖SGK1 Gene60%

see_also📖STAT1 Gene - Signal Transducer and Activator of Transcriptio60%

see_also📖TNF - Tumor Necrosis Factor60%

see_also📖OTULIN — OTU Deubiquitinase with Linear Linkage Specificity60%

see_also📖Packard Center for ALS Research60%

see_also📖Aquaporin-4 Protein60%

see_also📖AT(N) Biomarker Classification for Alzheimer's Disease60%

see_also📖A/T/N+ Comprehensive Biomarker Panel for Alzheimer's Di60%

see_also📖Combination Biomarker Panels for Alzheimer's Disease60%

see_also📖Tumor Necrosis Factor Alpha (TNF-α) as a Neurodegenerative D60%

see_also📖Cholinergic Basal Forebrain Neurons in Alzheimer's Dise60%

see_also📖Cerebellar Granule Cells in Neurodegenerative Disease60%

see_also📖Cerebellar Neurons in Creutzfeldt-Jakob Disease60%

see_also📖Cerebellar Purkinje Cells60%

see_also📖Cortical Layer 5 Pyramidal Neurons in Alzheimer's Disea60%

see_also📖Dentate Gyrus Granule Cells in Alzheimer's Disease60%

see_also📖Disease-Associated Microglia in Alzheimer's Disease60%

see_also📖Layer 2 Entorhinal Cortex Neurons in Early Alzheimer's 60%

see_also📖Entorhinal Cortex Layer II Neurons in Alzheimer's Disea60%

see_also📖Layer 2 Entorhinal Cortex Neurons in Alzheimer Disease60%

see_also📖Locus Coeruleus Noradrenergic Neurons in Alzheimer's Di60%

see_also📖Locus Coeruleus Norepinephrine in AD60%

see_also📖Pedunculopontine Nucleus Cholinergic Neurons in Lewy Body Di60%

see_also📖Pedunculopontine Nucleus Neurons in Lewy Body Disease60%

see_also📖Spinal Cord Interneurons in Motor Neuron Disease60%

see_also📖Temporal Cortex Neurons in Alzheimer's Disease60%

see_also📖AMDX-2011P Phase 2 Trial for Alzheimer's Disease60%

see_also📖AMDX-2011P Retinal Amyloid Tracer in Alzheimer's Diseas60%

see_also📖Benfotiamine Phase 2 Alzheimer's Disease Trial (NCT062260%

see_also📖Bilingualism Cognitive Reserve AD Trial60%

see_also📖Lactococcus lactis CKDB001 for Alzheimer's Disease (NCT60%

see_also📖LY-3372689 MAGNOLIA Trial - Phase 2 in Alzheimer's Dise60%

see_also📖Methylphenidate + iTBS for Apathy in AD (PRIME Trial)60%

see_also📖MK-1167 Phase 2 Alzheimer's Disease Trial60%

see_also📖Gabapentin Enacarbil Phase 4 Trial - Nighttime Agitation60%

see_also📖NCT04840979 - Genetic Variants Affecting Microglial Activati60%

see_also📖NCT07138677: MCI Network Guided TMS for Early Alzheimer'60%

see_also📖RO7812653 for Early Symptomatic Alzheimer's Disease60%

see_also📖TTYP01 Phase 2 Alzheimer's Disease Trial60%

see_also📖XTR006 Tau PET for Alzheimer's Disease (NCT07115238)60%

see_also📖Accelerating Medicines Partnership Alzheimer's Disease 60%

see_also📖diseases-motoneuron-disease60%

see_also📖Neurodegeneration60%

see_also📖Tumor Necrosis Factor (TNF)60%

see_also📖Experiment: Autoimmune Hypothesis Testing in AD60%

see_also📖Experimental: CAAR-T Cell Therapy for Autoantibody-Mediated 60%

see_also📖SCFA-Mediated Neuroinflammation in Alzheimer's Disease60%

see_also📖Alzheimer Indonesia60%

see_also📖Accelerating Medicines Partnership for Alzheimer's Dise60%

see_also📖Cerebrovascular Disease in Neurodegeneration60%

see_also📖Cholinergic Hypothesis in Alzheimer's Disease60%

see_also📖cross-disease60%

see_also📖Glia-Neuron Crosstalk in Alzheimer's Disease60%

see_also📖Glymphatic System in Alzheimer's Disease60%

see_also📖Infectious Etiology Hypotheses in Alzheimer's Disease60%

see_also📖Infectious Triggers in Alzheimer's Disease60%

see_also📖Innate Immune Signaling Pathways in Alzheimer's Disease60%

see_also📖Integrated Stress Response in Alzheimer's Disease60%

see_also📖IVNS1ABP Mutation: Progeria-Like Disease with Neurological D60%

see_also📖Microglial State Trajectory from Mobilization to Dysregulati60%

see_also📖mitochondrial-dysfunction-ad60%

see_also📖Neuronal Death Pathways in Alzheimer's Disease60%

see_also📖PKM2 Metabolic Dysregulation in Alzheimer's Disease60%

see_also📖psilocybin-neuropsychiatric-ad60%

see_also📖RNA Metabolism Dysregulation in Alzheimer's Disease60%

see_also📖Sleep Disruption in Alzheimer's Disease60%

see_also📖Tumor-Derived Cystatin C Enables Amyloid Clearance60%

see_also📖Vascular Contributions to Alzheimer's Disease60%

see_also📖Seattle Alzheimer's Disease Brain Cell Atlas (SEA-AD)60%

see_also📖CAR-A (Chimeric Antigen Receptor) Astrocyte Therapy for Alzh60%

see_also📖Ferulic Acid Carbamate Derivatives for Alzheimer's Dise60%

see_also📖Amyloid Beta 40 (Aβ40) - Biomarker60%

see_also📖Amyloid PET Imaging - Diagnostic Biomarker60%

see_also📖DNA Methylation Biomarkers in Neurodegeneration60%

see_also📖Amyloid-Beta Accumulating Neurons60%

see_also📖Amyloid-Beta Metabolism in Cortical Neurons60%

see_also📖Amyloid-Beta-Exposed Neurons60%

see_also📖amyloid-responsive-microglia60%

see_also📖Betz Cells in Amyotrophic Lateral Sclerosis60%

see_also📖DNA Damage-Accumulating Neurons in Neurodegeneration60%

see_also📖DNA Damage and Repair in Neurons60%

see_also📖Cortical GABAergic Interneurons in Amyotrophic Lateral Scler60%

see_also📖Motor Cortex in Amyotrophic Lateral Sclerosis60%

see_also📖Oculomotor Neurons in Amyotrophic Lateral Sclerosis60%

see_also📖Spinal Cord Motor Neurons in Amyotrophic Lateral Sclerosis60%

see_also📖Spinal Cord Neurons in Amyotrophic Lateral Sclerosis60%

see_also📖Spinal Cord Motor Neurons in Amyotrophic Lateral Sclerosis60%

see_also📖Upper Motor Neurons in Amyotrophic Lateral Sclerosis60%

see_also📖Alzheimer Hippocampal Circuit60%

see_also📖amiloride-als60%

see_also📖atl1103-antisense-als60%

see_also📖Creatine ALS Trial60%

see_also📖D-Cycloserine ALS Trial60%

see_also📖Edaravone ALS Trial60%

see_also📖Gabapentin ALS Trial60%

see_also📖Idebenone ALS Trial60%

see_also📖Intravenous Immunoglobulin (IVIG) in ALS Trial60%

see_also📖Lithium Carbonate in Amyotrophic Lateral Sclerosis60%

see_also📖Lithium Continuation in ALS Trial60%

see_also📖Masitinib ALS Trial60%

see_also📖Low-Dose Naltrexone ALS Trial60%

see_also📖nimodipine-als60%

see_also📖Riluzole ALS Trials60%

see_also📖Sargramostim (GM-CSF) ALS Trial60%

see_also📖Sodium Phenylbutyrate ALS Trial60%

see_also📖Tauraso (Nimodipine) ALS Trial60%

see_also📖High-Dose Vitamins ALS Trial60%

see_also📖DNA Damage Response in Corticobasal Syndrome60%

see_also📖Amyloid PET Imaging60%

see_also📖Apoptosis in Neurodegeneration60%

see_also📖Amyloid Precursor Protein (APP)60%

see_also📖Amyloid-Related Imaging Abnormalities (ARIA)60%

see_also📖IL6 (Redirect)60%

see_also📖entities-psen160%

see_also📖entities-psen260%

see_also📖entities-tnf60%

see_also📖DNA Damage Repair Deficiency Validation Study in Parkinson&#60%

see_also📖Environmental Exposure Causal Attribution in ALS — Experimen60%

see_also📖Microbiome-Gut Barrier Signatures in ALS — Experiment Design60%

see_also📖Sleep and Respiratory Network Interaction in ALS — Experimen60%

see_also📖ALS Trial Failures Knowledge Gap60%

see_also📖Genes60%

see_also📖APH1B Gene - Anterior Pharynx Defective 1 Homolog B60%

see_also📖apoe60%

see_also📖app60%

see_also📖DAPK1 Gene60%

see_also📖DHCR24 Gene60%

see_also📖EIF2AK2 — Eukaryotic Translation Initiation Factor 2 Alpha K60%

see_also📖FAS Gene60%

see_also📖HMGCR — 3-Hydroxy-3-Methylglutaryl-CoA Reductase60%

see_also📖IL1B Gene - Interleukin 1 Beta60%

see_also📖IL6 - Interleukin 660%

see_also📖LMNA Gene60%

see_also📖mapt60%

see_also📖NCSTN Gene - Nicastrin60%

see_also📖PARP1 Gene60%

see_also📖PEN2 Gene60%

see_also📖PSEN1 — Presenilin 160%

see_also📖PSEN2 — Presenilin 260%

see_also📖SREBF1 Gene60%

see_also📖Amyloid plaque and neurofibrillary tangle deposition is an e60%

see_also📖hypotheses-apoe-contributes-alzheimers-disease-regulat60%

see_also📖DNA Damage Repair Deficiency Hypothesis in Parkinson's 60%

see_also📖DNA Damage Repair Therapy - Biomarker Guided60%

see_also📖APP Gene Dosage Reduction Therapy for Down Syndrome60%

see_also📖alzheimer-europe60%

see_also📖Alzheimer Indonesia60%

see_also📖Healey Center for ALS60%

see_also📖Packard Center for ALS Research60%

see_also📖Amyloid Therapeutics: Investment Landscape Analysis60%

see_also📖Apoptosis Inhibitors for Neurodegeneration — Investment Land60%

see_also📖DNA Damage Repair Investment Landscape60%

see_also📖Amyloid-Beta Aggregation and Plaque Formation60%

see_also📖amyloid-beta-cellular-uptake60%

see_also📖Amyloid-beta Cellular Uptake Pathway60%

see_also📖Amyloid-beta Degradation Pathways60%

see_also📖Amyloid-beta Fibril Formation60%

see_also📖Amyloid-beta Fibril Formation Pathway60%

see_also📖amyloid-beta-metalloproteinases60%

see_also📖Amyloid-beta Oligomerization Pathway60%

see_also📖Amyloid-beta Trans-synaptic Spread Pathway60%

see_also📖Amyloid Cascade Pathway60%

see_also📖amyloid-cascade-hypothesis60%

see_also📖amyloid-cascade-pathway60%

see_also📖Amyloid-Beta Clearance Therapeutic Pathways60%

see_also📖Amyloid Conformational Strains60%

see_also📖amyloid-hypothesis60%

see_also📖Amyloid Oligomers in Neurodegeneration60%

see_also📖Amyloid-Tau Synergistic Interaction Hypothesis60%

see_also📖Amyloid-Tau Synergistic Interaction Hypothesis in Alzheimer&60%

see_also📖Amyloid vs Tau-First Hypothesis60%

see_also📖Amyloid vs Tau-First Hypothesis in Alzheimer's Disease60%

see_also📖Apoptosis Pathway in Neurodegeneration60%

see_also📖Apoptosis Pathways in Alzheimer's Disease60%

see_also📖Apoptosis in Neurodegeneration60%

see_also📖Apoptosis Pathways in Parkinson's Disease60%

see_also📖DNA Damage Response in Alzheimer's Disease60%

see_also📖dna-damage-repair60%

see_also📖DNA Damage Repair Mechanisms Across Neurodegenerative Diseas60%

see_also📖DNA Damage Response Impairment Pathway60%

see_also📖DNA Damage Response in 4R-Tauopathies60%

see_also📖DNA Damage Response in Alzheimer's Disease60%

see_also📖DNA Damage Response in Corticobasal Syndrome60%

see_also📖DNA Damage Response and Repair in Neurodegeneration60%

see_also📖DNA Damage Response in Neurons60%

see_also📖DNA Damage Response in Parkinson's Disease60%

see_also📖DNA Damage Response in Neurodegeneration60%

see_also📖DNA Methylation in Neurodegeneration60%

see_also📖DNA Repair Mechanisms in Neurodegeneration60%

see_also📖DNA Sensing Pathways in Neurodegeneration60%

see_also📖Dynein Motor Protein60%

see_also📖Epigenetics in Amyotrophic Lateral Sclerosis60%

see_also📖mitochondrial-dysfunction-als60%

see_also📖viral-post-infectious-als60%

see_also📖ApoE (Apolipoprotein E)60%

see_also📖APP Protein60%

see_also📖Dynein — Cytoplasmic Dynein 160%

see_also📖FAS Protein60%

see_also📖IL1B — Interleukin-1 Beta60%

see_also📖LMNA Protein60%

see_also📖NCSTN Protein60%

see_also📖PARP1 (Poly(ADP-Ribose) Polymerase 1)60%

see_also📖Presenilin Enhancer 2 (PEN-2) Protein60%

see_also📖PEN2 Protein60%

see_also📖PSEN1 Protein (Presenilin-1)60%

see_also📖PSEN2 Protein (Presenilin-2)60%

see_also📖Amyloid Immunotherapy Vaccines for Alzheimer's Disease60%

see_also📖DNA Damage Repair Therapy for Neurodegeneration60%

see_also📖DNA Repair Therapy for Neurodegeneration60%

related🧪Glymphatic System-Enhanced Antibody Clearance Reversal55%

related🧪SASP-Driven Aquaporin-4 Dysregulation55%

related🧪Aquaporin-4 Polarization Rescue55%

related🧪LRP1-Dependent Tau Uptake Disruption55%

related🧪TFAM overexpression creates mitochondrial donor-recipient gr55%

related🧪TREM2 Conformational Stabilizers for Synaptic Discrimination55%

related🧪APOE-TREM2 Interaction Modulation55%

related🧪TREM2-Mediated Selective Aggregate Clearance Pathway55%

related🧪TREM2-Dependent Microglial Senescence Transition55%

related🧪TREM2-mediated microglial tau clearance enhancement55%

related🧪Cell-Type Specific TREM2 Upregulation in DAM Microglia55%

mentions🧪LRP1-Dependent Tau Uptake Disruption50%

mentions🧪Selective APOE4 Degradation via Proteolysis Targeting Chimer50%

mentions🧪APOE4 Allosteric Rescue via Small Molecule Chaperones50%

mentions🧪Interfacial Lipid Mimetics to Disrupt Domain Interaction50%

mentions🧪Targeted APOE4-to-APOE3 Base Editing Therapy50%

mentions🧪Competitive APOE4 Domain Stabilization Peptides50%

mentions🧪APOE Isoform Expression Across Glial Subtypes50%

mentions🧪Glymphatic System-Enhanced Antibody Clearance Reversal50%

mentions🧪SASP-Driven Aquaporin-4 Dysregulation50%

mentions🧪Aquaporin-4 Polarization Rescue50%

mentions🧪Glial Glycocalyx Remodeling Therapy50%

mentions🧪PARP1 Inhibition Therapy50%

related🔬Investigate prion-like spreading of tau pathology through co50%

related🔬Analyze circuit-level changes in neurodegeneration using All50%

related🔬Investigate prion-like spreading of tau pathology through co50%

related🔬What are the mechanisms underlying tdp-43 phase separation t50%

related🔬What are the mechanisms underlying blood-brain barrier trans50%

related🔬What are the mechanisms underlying protein aggregation cross50%

related🔬What are the mechanisms underlying mechanistic role of apoe 50%

see_also📖Cell-Free DNA Biomarkers in Neurodegeneration45%

see_also📖Exosomal Biomarkers in Neurodegeneration45%

see_also📖Exosomal miR-155 in Neurodegeneration45%

see_also📖IL-6 (Interleukin-6) in Neurodegeneration45%

see_also📖Liquid Biopsy in Neurodegeneration45%

see_also📖Metabolomic Biomarkers in Neurodegeneration45%

see_also📖Neuroimaging Biomarkers for Neurodegeneration45%

see_also📖Synaptic Biomarkers in Neurodegeneration45%

see_also📖BEACoN Study - Biomarker Exploration in Aging, Cognition and45%

see_also📖LX1001 Phase 1/2 Trial (NCT03634007) - Gene Therapy for APOE45%

see_also📖KarXT for Alzheimer's Disease Cognitive Impairment - MI45%

see_also📖A Phase 3, Randomised, Double-blinded, Placebo-controlled St45%

see_also📖Novartis Alzheimer's Disease Phase 2 Trial (NCT0709451645%

see_also📖Olfactory Mucosa, Blood and Urine for Identification of Earl45%

see_also📖Rotigotine and Rivastigmine Combination Therapy for Alzheime45%

see_also📖Swedish BioFINDER 2 Study: Biomarkers and Neurodegeneration 45%

see_also📖APOE4 (Apolipoprotein E4)45%

see_also📖Beta-Propeller Protein-Associated Neurodegeneration (BPAN)45%

see_also📖Cross-National Cancer-Dementia Correlation and Shared Diseas45%

see_also📖Cancer-Dementia Inverse Correlation: Epidemiological Evidenc45%

see_also📖China Neurodegeneration Epidemiology45%

see_also📖DALY Methodology — Neurodegeneration45%

see_also📖Disease Progression & Staging in Neurodegeneration45%

see_also📖Economic Burden — Neurodegeneration45%

see_also📖European Neurodegeneration Epidemiology45%

see_also📖Familial vs Sporadic Neurodegeneration Comparison45%

see_also📖Global Neurodegeneration Epidemiology45%

see_also📖India Neurodegeneration Epidemiology45%

see_also📖Japan Neurodegeneration Epidemiology45%

see_also📖Manganese-Related Neurodegeneration (Manganism)45%

see_also📖mitochondrial-dysfunction-neurodegeneration-comparison45%

see_also📖Mitochondrial Diseases and Neurodegeneration Comparison Matr45%

see_also📖Mitochondrial Membrane Protein-Associated Neurodegeneration 45%

see_also📖Neurodegeneration with Brain Iron Accumulation (NBIA)45%

see_also📖Potential Impact Measures — Neurodegeneration45%

see_also📖Pantothenate Kinase-Associated Neurodegeneration (PKAN)45%

see_also📖PLA2G6-Associated Neurodegeneration (PLAN)45%

see_also📖Sleep Disorders in Neurodegeneration45%

see_also📖US Neurodegeneration Epidemiology45%

see_also📖SNCA — Alpha-Synuclein Gene Entity Page45%

see_also📖Extracellular Vesicle and Tunneling Nanotube-Mediated Spread45%

see_also📖acetylcholine-signaling-neurodegeneration45%

see_also📖Advanced Glycation End Products in Neurodegeneration45%

see_also📖Advanced In Vitro Models for Neurodegeneration — Organoids, 45%

see_also📖Amylin Signaling in Neurodegeneration45%

see_also📖Antibody Therapy in Neurodegeneration45%

see_also📖Antisense Oligonucleotide (ASO) Therapy in Neurodegeneration45%

see_also📖Autosis Pathway in Neurodegeneration45%

see_also📖Axon Guidance Pathways in Neurodegeneration45%

see_also📖Basal Ganglia Circuit Dysfunction in Neurodegeneration45%

see_also📖becn1-autophagy-initiation-neurodegeneration-causal-chain45%

see_also📖CaMKII Signaling Pathway in Neurodegeneration45%

see_also📖Carbonic Anhydrase Modulator Therapy in Neurodegeneration45%

see_also📖Cerebral Amyloid Angiopathy in Neurodegeneration45%

see_also📖Cerebral Amyloid Angiopathy Pathway in Neurodegeneration45%

see_also📖Cholinergic System Dysfunction in Neurodegeneration45%

see_also📖Chrononutrition and Time-Restricted Eating in Neurodegenerat45%

see_also📖Neural Circuits in Neurodegeneration45%

see_also📖Cognitive Reserve and Resilience in Neurodegeneration45%

see_also📖Computational Disease Models for Neurodegeneration45%

see_also📖Convergent Pathways in Neurodegeneration45%

see_also📖Copper Homeostasis in Neurodegeneration45%

see_also📖COVID-19 Neurodegeneration Mechanism45%

see_also📖Diffusion MRI (DTI) in Neurodegeneration45%

see_also📖Digital Phenotyping in Neurodegeneration45%

see_also📖Down Syndrome Neurodegeneration Pathway45%

see_also📖Dystrophic Neurites in Neurodegeneration45%

see_also📖Endocannabinoid System in Neurodegeneration45%

see_also📖Endosomal-Lysosomal Pathway in Neurodegeneration45%

see_also📖Endosomal Sorting Defects in Neurodegeneration45%

see_also📖Endothelin Signaling Pathway in Neurodegeneration45%

see_also📖epigenetics-neurodegeneration45%

see_also📖ESCRT-III Inhibition by Alpha-Synuclein in Neurodegeneration45%

see_also📖FA2H-Associated Neurodegeneration Pathway45%

see_also📖Farnesoid X Receptor (FXR) Signaling in Neurodegeneration45%

see_also📖Galectin-3 Mechanism in Neurodegeneration45%

see_also📖Gangliosides in Neurodegeneration45%

see_also📖GDF15/GDF11 Signaling in Neurodegeneration45%

see_also📖GDNF Signaling Pathway in Neurodegeneration45%

see_also📖Ghrelin Signaling Pathway in Neurodegeneration45%

see_also📖Glucocorticoid Signaling Pathway in Neurodegeneration45%

see_also📖Glycosylation in Neurodegeneration45%

see_also📖gp130/IL-6 Family Cytokine Signaling in Neurodegeneration45%

see_also📖Hippocampal Neurogenesis in Neurodegeneration45%

see_also📖Histone Modification Pathways in Neurodegeneration45%

see_also📖HMGB1 Signaling in Neurodegeneration45%

see_also📖Homocysteine Neurotoxicity and Neurodegeneration45%

see_also📖IGF-1 Signaling Pathway in Neurodegeneration45%

see_also📖IL-1 Signaling Pathway in Neurodegeneration45%

see_also📖Integrated Stress Response in Neurodegeneration45%

see_also📖interleukin-6-signaling-neurodegeneration45%

see_also📖Intrinsic Apoptosis Pathway in Neurodegeneration45%

see_also📖Ion Channel Dysfunction in Neurodegeneration: Cross-Disease 45%

see_also📖Kidney-Brain Neurodegeneration Axis45%

see_also📖Lipid Dysregulation in Neurodegeneration45%

see_also📖Lipid Metabolism Dysregulation in Neurodegeneration45%

see_also📖Lysosomal Calcium Dysregulation in Neurodegeneration45%

see_also📖Magnetic Resonance Spectroscopy in Neurodegeneration45%

see_also📖Metal Homeostasis Dysregulation in Neurodegeneration45%

see_also📖Metal Homeostasis in Neurodegeneration45%

see_also📖Microglial Priming Pathway in Neurodegeneration45%

see_also📖MicroRNA Dysfunction in Neurodegeneration45%

see_also📖Mineralocorticoid Receptor Signaling in Neurodegeneration45%

see_also📖Mitochondrial Dynamics Pathway in Neurodegeneration45%

see_also📖Mitochondrial Fusion in Neurodegeneration45%

see_also📖Molecular Chaperones in Neurodegeneration45%

see_also📖mTOR Signaling in Neurodegeneration45%

see_also📖mTOR Signaling Pathway in Neurodegeneration45%

see_also📖Neural Circuit Disruption in Neurodegeneration45%

see_also📖Neurexin/Neuroligin Synaptic Adhesion Modulator Therapy in N45%

see_also📖Neurofilament Light Chain (NfL) Mechanism in Neurodegenerati45%

see_also📖Neuronal Hyperexcitability in Neurodegeneration45%

see_also📖Neuropil Threads in Neurodegeneration45%

see_also📖Neurotensin Signaling in Neurodegeneration45%

see_also📖Neurovascular Unit Dysfunction in Neurodegeneration45%

see_also📖NF-kB Signaling Pathway in Neurodegeneration45%

see_also📖Nitric Oxide Signaling in Neurodegeneration45%

see_also📖NLRP3 Inflammasome Inhibitors for Parkinson's Disease45%

see_also📖Noradrenergic Signaling Pathway in Neurodegeneration45%

see_also📖Neuropeptide Y Signaling in Neurodegeneration45%

see_also📖NRF2 Signaling Pathway in Neurodegeneration45%

see_also📖Nuclear Pore Complex Dysfunction in Neurodegeneration45%

see_also📖Orexin Signaling in Neurodegeneration45%

see_also📖OSK Reprogramming and Yamanaka Factors in Neurodegeneration45%

see_also📖P-Body (Processing Body) Pathway in Neurodegeneration45%

see_also📖Paranodal Dysfunction in Neurodegeneration45%

see_also📖Paraptosis in Neurodegeneration45%

see_also📖Parthanatos in Neurodegeneration45%

see_also📖Pericyte Loss in Neurodegeneration45%

see_also📖Peripheral Immune-Brain Crosstalk in Neurodegeneration45%

see_also📖PKR Pathway in Neurodegeneration45%

see_also📖PPAR Signaling Pathway in Neurodegeneration45%

see_also📖Prion Diseases in Neurodegeneration45%

see_also📖Prion-Like Spread in Neurodegeneration45%

see_also📖Prion Protein Metabolism in Neurodegeneration45%

see_also📖Progesterone Signaling Pathway in Neurodegeneration45%

see_also📖Prognostic Biomarkers in Neurodegeneration45%

see_also📖Protein Aggregation Comparison in Neurodegeneration45%

see_also📖Protein Aggregation Seeds in Neurodegeneration45%

see_also📖Protein O-GlcNAcylation Pathway in Neurodegeneration45%

see_also📖Cortical Involvement and Neurodegeneration in Progressive Su45%

see_also📖Purinergic Signaling in Neurodegeneration45%

see_also📖Quantum Biology and Coherent Energy Transfer in Neurodegener45%

see_also📖R-Loop Stress in Neurodegeneration45%

see_also📖RAN Translation in Neurodegeneration45%

see_also📖Retinal Degeneration Pathway in Neurodegeneration45%

see_also📖Ribosome Dysfunction in Neurodegeneration45%

see_also📖RNA Splicing in Neurodegeneration45%

see_also📖RNA-Targeted Therapies in Neurodegeneration45%

see_also📖Ribonuclease κ and Circular RNAs: A New Mechanism of Aging a45%

see_also📖S100 Protein Signaling Pathway in Neurodegeneration45%

see_also📖Senescent Cell Clearance in Neurodegeneration45%

see_also📖Serotonergic Dysfunction in Neurodegeneration45%

see_also📖Sex Differences in Neurodegeneration45%

see_also📖Short Chain Fatty Acids in Neurodegeneration45%

see_also📖Sigma-1 Receptor Signaling in Neurodegeneration45%

see_also📖Sirtuin-Mitochondrial Biogenesis Axis in Neurodegeneration45%

see_also📖Sleep Dysfunction in Neurodegeneration45%

see_also📖SUMOylation in Neurodegeneration45%

see_also📖synaptic-vesicle-cycling-neurodegeneration45%

see_also📖Synthetic Lethality and PARP Inhibition in Neurodegeneration45%

see_also📖T-Cell Dysfunction in Neurodegeneration45%

see_also📖Tertiary Lymphoid Organs in Neurodegeneration45%

see_also📖Therapeutic Targets in Neurodegeneration45%

see_also📖Transdiagnostic Proteomic Changes in Neurodegeneration45%

see_also📖ubiquitin-proteasome-dysfunction-neurodegeneration45%

see_also📖Ubiquitin-Proteasome System Dysfunction in Neurodegeneration45%

see_also📖Vagus Nerve Pathway in Neurodegeneration45%

see_also📖VEGF Signaling and Cerebral Angiogenesis in Neurodegeneratio45%

see_also📖vip-vasoactive-intestinal-peptide-signaling-neurodegeneratio45%

see_also📖WNK1-Bilirubin Signaling in Neuroinflammation and Neurodegen45%

see_also📖Wnt/β-Catenin Signaling Pathway in Neurodegeneration45%

mentions🔬Analyze circuit-level changes in neurodegeneration using All40%

related🧪LRP1-Dependent Tau Uptake Disruption40%

related🧪Selective APOE4 Degradation via Proteolysis Targeting Chimer40%

related🧪APOE Isoform Conversion Therapy40%

related🧪APOE4 Allosteric Rescue via Small Molecule Chaperones40%

related🧪Interfacial Lipid Mimetics to Disrupt Domain Interaction40%

related🧪Targeted APOE4-to-APOE3 Base Editing Therapy40%

related🧪APOE4-Selective Lipid Nanoemulsion Therapy40%

related🧪Competitive APOE4 Domain Stabilization Peptides40%

related🧪APOE Isoform Expression Across Glial Subtypes40%

related🧪Glycosaminoglycan Template Disruption Approach40%

related🧪Glial Glycocalyx Remodeling Therapy40%

related🧪PARP1 Inhibition Therapy40%